SCHEMBL6170877

SCHEMBL6170877

COC(=O)/C=C/c1cc(OC)ccc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JUN P05412 1/20 0.53
NFKB1 P19838 1/20 0.53
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 3/20 0.49
MAPT P10636 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ABCG2 Q9UNQ0 1/20 0.49
KDM4E B2RXH2 1/20 0.49
TP53 P04637 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
CYP2C19 P33261 1/20 0.49
HSD17B10 Q99714 1/20 0.49
GABRA3 P34903 1/20 0.48
GABRA2 P47869 1/20 0.48
GABRB2 P47870 1/20 0.48
RELA Q04206 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170881 1.00 JUN (0.53) JUNNFKB1TDP1ALDH1A1MAPT
SCHEMBL706048 0.88 MAPT (0.53) JUNNFKB1TDP1ALDH1A1MAPT
SCHEMBL6169857 0.88 MAPT (0.53) JUNNFKB1TDP1ALDH1A1MAPT
SCHEMBL8125948 0.86 THRB (0.56) JUNNFKB1ALDH1A1MAPTMEN1
SCHEMBL8125950 0.86 THRB (0.56) JUNNFKB1ALDH1A1MAPTMEN1
SCHEMBL671449 0.84 ERN1 (0.54) JUNNFKB1TDP1ALDH1A1MAPT
SCHEMBL671450 0.84 ERN1 (0.54) JUNNFKB1TDP1ALDH1A1MAPT
SCHEMBL6171251 0.84 ALDH1A1 (0.43) JUNNFKB1ALDH1A1MAPTMEN1
SCHEMBL6171241 0.84 ALDH1A1 (0.43) JUNNFKB1ALDH1A1MAPTMEN1
SCHEMBL6169914 0.83 ALDH1A1 (0.50) TDP1ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1065204-B1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER (US) 2002-04-10 EP disclosed
US-6303628-B1 FOR THE TREATMENT OF A MEDICAL CONDITION IN WHICH PROSTAGLANDINS ARE IMPLICATED AS PATHOGENS IN MAMMALS PFIZER INC 2001-10-16 US disclosed
EP-1065204-A1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER INC. (US) 2001-01-03 EP disclosed